SHENGKUI/KIWA
--------------------------------------------------------------------------------


Kiwa Bio-Tech Signs One-Year Contract For $34 Million

Claremont,  CA, August 2, 2006 Kiwa Bio-Tech Products Group Corporation  (OTCBB:
KWBT) has signed  with China Hua Yang  Roneo  Corporation.  China Hua Yang Roneo
Corporation  has agreed to order  200,000  tons of urea.  The urea will be mixed
with Kiwa's products, particularlyKiwa Yimuling, a bio-fertilizer, which will be
sold pursuant to a separate contract to be entered into between the parties. The
term of the agreement is 18 months and is extendable for an additional period of
six  months.  The value of the  contract is  US$34,000,000,  based on a value of
US$170 per metric ton.

China Hua Yang  Roneo  Corporation  is a  subsidiary  of China  Council  for the
Promotion of  International  Trade, and sells Chinese products to Southeast Asia
and European countries.

The products  covered by this contract will primarily be exported to Philippines
and Viet Nam. In order to meet the  requirements  of clients in Philippines  and
Viet Nam, the R&D Center of Kiwa has focused on  developing a scientific  way to
use Kiwa  Yimuling  bio-fertilizers  compounded  with  urea.  Currently,  Kiwa's
products have passed tests in Viet Nam, and the Ministry of  Agriculture of Viet
Nam is expected to issue a distribution license for Kiwa's products in August.

In order to meet its obligation to supply urea,  Kiwa has signed a contract with
Shengkui  Technologies,  Inc. to purchase from Shengkui 1,200,000 metric tons of
prilled urea N 46% agricultural  grade conforming to certain  specifications set
forth in the agreement. The term of the agreement is 18 months and is extendable
for an  additional  period of six  months.  The  aggregate  value of  contracted
deliveries under the agreement is approximately US$162,000,000, based on a value
of US$135 per metric ton.


For more details on these contracts including delivery  commitments and terms of
credit and purchase, please refer to the 8k report filed by Kiwa with the United
States  Securities  and  Exchange  Commission  are  available  free of charge at
http://www.sec.gov.

About Kiwa Bio-Tech Products Group Corporation

The Company  develops,  manufactures,  and distributes  and markets  innovative,
cost-effective,   and  environmentally  safe   bio-technological   products  for
agricultural and natural resources and environmental conservation. The Company's
products  are  designed to enhance the quality of human life by  increasing  the
value,   quality  and   productivity   of  crops  and  decreasing  the  negative
environmental  impact of chemicals and other wastes.  For more information about
the Company, please visit the Company's website at http://www.kiwabiotech.com.



SHENGKUI/KIWA
--------------------------------------------------------------------------------

This  press  release  contains  information  that  constitutes   forward-looking
statements made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Any such forward-looking  statements involve risk
and uncertainties  that could cause actual results to differ materially from any
future results described by the  forward-looking  statements.  Risk factors that
could contribute to such differences  include those matters more fully disclosed
in the Company's reports filed with the Securities and Exchange Commission.  The
forward-looking  information  provided herein represents the Company's estimates
as of the date of the press release,  and subsequent events and developments may
cause the Company's estimates to change. The Company specifically  disclaims any
obligation to update the forward-looking  information in the future.  Therefore,
this  forward-looking  information should not be relied upon as representing the
Company's  estimates  of  its  future  financial  performance  as  of  any  date
subsequent to the date of this press release.

 Contact:
 Kiwa Bio-Tech Products Group Corporation
 Yvonne Wang
 626 715 5855

 Jessie Wang
 011-8610-85286177
 wangxiaobei@kiwabiotech.com

 Investor Relations
 Robert Schechter
 Corporate Insights/Equity Communications
 (646) 234 3624 rschechter@corp-insights.com